Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Sarin-Induced Neuroinflammation in Mouse Brain Is Attenuated by the Caspase Inhibitor Q-VD-OPh

Journal of Pharmacology and Experimental Therapeutics(2023)10.1124/jpet.123.001820Source: DataRank Database

Sarin-Induced Neuroinflammation in Mouse Brain Is Attenuated by the Caspase Inhibitor Q-VD-OPh is a research paper published in Journal of Pharmacology and Experimental Therapeutics (2023). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 2.87)OA: hybridTopics (70)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

William C. Grunwald,Teresa L. Garrett,Thomas L. Brown ORCID,David R. Cool ORCID,Ekta Shah ORCID

Live enrichment

PubMed:37918856 PMC:PMC10801781 OpenAlex:https://openalex.org/W4388210963

NINDS NIH HHS

Grant: R21 NS072103

National Institutes of Health

Grant: 5R21NS072103-02

Protection against sarin-induced neurotoxicity via an in vivo caspase inhibitor

FWCI

2.87

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

hybridLicense: cc-by

journalhttps://jpet.aspetjournals.org/content/jpet/early/2023/11/02/jpet.123.001820.full.pdf

publisherhttps://jpet.aspetjournals.org/content/jpet/early/2023/11/02/jpet.123.001820.full.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0022356524171716?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0022356524171716?httpAccept=text/plain

publisherhttps://syndication.highwire.org/content/doi/10.1124/jpet.123.001820

Fields of Study

Pesticide Exposure and ToxicityTrace Elements in HealthVitamin C and Antioxidants Research03 medical and health sciences0302 clinical medicine

MeSH Terms

Nerve AgentsNeuroinflammatory DiseasesAmino Acid Chloromethyl KetonesAnimalsBrainInflammationKetonesMice, Inbred C57BLOrganophosphatesQuinolinesSarinSeizuresCytokinesCaspasesMiceInflammasomesCaspase Inhibitors

Keywords

SarinNeuroinflammationPharmacologyChemistryNerve agentNeuroprotectionProinflammatory cytokineCaspase 1EndocrinologyInternal medicineInflammasomeMedicineAcetylcholinesteraseInflammationBiochemistryEnzymeSarin* / toxicityInflammasomesSpecial Section on Medical CountermeasuresSeizures / drug therapyKetones / adverse effectsAmino Acid Chloromethyl KetonesMiceSeizuresInflammation / drug therapyAmino Acid Chloromethyl Ketones*Quinolines*AnimalsCaspase Inhibitors / therapeutic useSeizures / chemically inducedNeuroscience and NeurobiologyNeurosciencesOrganophosphates / pharmacologyBrainKetonesCaspase InhibitorsOrganophosphatesMice, Inbred C57BLNeurologyMedical NeurobiologyCaspasesNeuroinflammatory DiseasesQuinolinesCytokinesNerve Agents* / pharmacologyInflammation / chemically inducedCaspase Inhibitors / pharmacologyNerve Agents

Sustainable Development Goals

SDG 0: Good health and well-being